File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/j.1745-7254.2005.00066.x
- Scopus: eid_2-s2.0-18744399885
- PMID: 15842786
- WOS: WOS:000229103500021
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Effects of {2-[(3-carboxy-1-oxoprogy1)amino]-2-deoxy-D-glucose} on human hepatocellular carcinoma cell line
Title | Effects of {2-[(3-carboxy-1-oxoprogy1)amino]-2-deoxy-D-glucose} on human hepatocellular carcinoma cell line |
---|---|
Authors | |
Keywords | Apoptosis Hepatoma HepG2 2-[(3-carboxy-1-oxoprogyl)amino]-2-deoxy-D- glucose |
Issue Date | 2005 |
Publisher | Nature Publishing Group. The Journal's web site is located at http://www.nature.com/aps/index.html |
Citation | Acta Pharmacologica Sinica, 2005, v. 26 n. 5, p. 635-640 How to Cite? |
Abstract | Aim: To study the effects of {2-[(3-carboxy-1-oxoprogyl)amino]-2-deoxy-D- glucose (COPADG) on cultured human hepatocellular carcinoma cells (HepG2). Methods: HepG2 cells were cultured in RPMI-1640 medium. Cell proliferation was determined by MTT assay. Apoptosis was determined by fluorescence microscopy, transmission electron microscopy, agarose gel electrophoresis of DNA fragmentation, and flow cytometry. Results: At the concentration ranging between 1-30 μmol/L, COPADG potently inhibited the growth and induced apoptosis of HepG2 cells. Conclusion: COPADG could effectively induce apoptosis in human hepatocellular carcinoma cells. More investigations are warranted for the potential use of this compound as a new agent for the non-surgical management of human hepatocellular carcinoma. ©2005 CPS and SIMM. |
Persistent Identifier | http://hdl.handle.net/10722/78182 |
ISSN | 2023 Impact Factor: 6.9 2023 SCImago Journal Rankings: 1.882 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wu, J | en_HK |
dc.contributor.author | Kou, W | en_HK |
dc.contributor.author | Gao, MT | en_HK |
dc.contributor.author | Zhou, YN | en_HK |
dc.contributor.author | Wang, AQ | en_HK |
dc.contributor.author | Xue, QJ | en_HK |
dc.contributor.author | Qiao, L | en_HK |
dc.date.accessioned | 2010-09-06T07:40:04Z | - |
dc.date.available | 2010-09-06T07:40:04Z | - |
dc.date.issued | 2005 | en_HK |
dc.identifier.citation | Acta Pharmacologica Sinica, 2005, v. 26 n. 5, p. 635-640 | en_HK |
dc.identifier.issn | 1671-4083 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/78182 | - |
dc.description.abstract | Aim: To study the effects of {2-[(3-carboxy-1-oxoprogyl)amino]-2-deoxy-D- glucose (COPADG) on cultured human hepatocellular carcinoma cells (HepG2). Methods: HepG2 cells were cultured in RPMI-1640 medium. Cell proliferation was determined by MTT assay. Apoptosis was determined by fluorescence microscopy, transmission electron microscopy, agarose gel electrophoresis of DNA fragmentation, and flow cytometry. Results: At the concentration ranging between 1-30 μmol/L, COPADG potently inhibited the growth and induced apoptosis of HepG2 cells. Conclusion: COPADG could effectively induce apoptosis in human hepatocellular carcinoma cells. More investigations are warranted for the potential use of this compound as a new agent for the non-surgical management of human hepatocellular carcinoma. ©2005 CPS and SIMM. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Nature Publishing Group. The Journal's web site is located at http://www.nature.com/aps/index.html | en_HK |
dc.relation.ispartof | Acta Pharmacologica Sinica | en_HK |
dc.subject | Apoptosis | en_HK |
dc.subject | Hepatoma | en_HK |
dc.subject | HepG2 | en_HK |
dc.subject | 2-[(3-carboxy-1-oxoprogyl)amino]-2-deoxy-D- glucose | en_HK |
dc.title | Effects of {2-[(3-carboxy-1-oxoprogy1)amino]-2-deoxy-D-glucose} on human hepatocellular carcinoma cell line | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1671-4083&volume=26&spage=635&epage=640&date=2005&atitle=Effects+of+{2-[(3-carboxy-1-oxoprogy1)amino]-2-deoxy-D-glucose}+on+human+hepatocellular+carcinoma+cell+line | en_HK |
dc.identifier.email | Qiao, L: lq8688@hotmail.com | en_HK |
dc.identifier.authority | Qiao, L=rp00513 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1111/j.1745-7254.2005.00066.x | en_HK |
dc.identifier.pmid | 15842786 | - |
dc.identifier.scopus | eid_2-s2.0-18744399885 | en_HK |
dc.identifier.hkuros | 132398 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-18744399885&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 26 | en_HK |
dc.identifier.issue | 5 | en_HK |
dc.identifier.spage | 635 | en_HK |
dc.identifier.epage | 640 | en_HK |
dc.identifier.isi | WOS:000229103500021 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Wu, J=7409254006 | en_HK |
dc.identifier.scopusauthorid | Kou, W=36800461200 | en_HK |
dc.identifier.scopusauthorid | Gao, MT=25629672200 | en_HK |
dc.identifier.scopusauthorid | Zhou, YN=7405364644 | en_HK |
dc.identifier.scopusauthorid | Wang, AQ=7404620465 | en_HK |
dc.identifier.scopusauthorid | Xue, QJ=36071456600 | en_HK |
dc.identifier.scopusauthorid | Qiao, L=7202151719 | en_HK |
dc.identifier.issnl | 1671-4083 | - |